Profile Picture

Dr Muhammad Mukhtiar

Assistant Professor (Ph.D.)

Dr Muhammad Mukhtiar

Assistant Professor (Ph.D.)

Research Area: Pharmaceutical Chemistry
About Me

Dr. Muhammad Mukhtiar is currently working as an Assistant Professor Department of the Pharmacy University of Poonch Rawalakot, He completed His graduation (B.Pharm) in 2002 and PhD in Pharmaceutical Chemistry from Gomal University D. I. Khan in 2014. He has also both professional and teaching experience in various organizations other than UPR, including GlaxoSmithKline, Abasyn University (Islamabad campus) Islamabad, and KUST University Kohat. He has published more than 35 research articles from 2013 to till date in peer-reviewed journals with the IF between 0.372 and 5.09.

Degree Major University Start Date End Date
Ph.D. Pharmaceutical Chemistry Gomal university D.I. KHAN.KPK. January 2008 April 2014
B.Pharm Pharmacy Gomal university D.I. KHAN.KPK. April 1998 August 2002
Designation Organization Duration
Assistant Professor Department of Pharmacy University of Poonch Rawalakot AJK May 2016 - May 2023
Assistant Professor Department of Pharmacy KUST Kohat KPK March 2015 - March 2016
Assistant Professor Department of Pharmacy Abasyn University Islamabad campus November 2013 - March 2015
Title Description Sponsoring Agency Amount Year
Designation Department Organization From Date To Date
Assistant Professor Pharmacy Kohat University of Science and Technology March, 2015 March, 2016
Assistant Professor Pharmacy Abasyn University Islamabad campus November, 2013 March, 2015
Description Year DOI
Humzah Jamshaid, Fakhar ud Din, Maimoona Malik, Muhammad Mukhtiar, HanGon Choi, Tofeeq Ur Rehman & Gul Majid Khan A cutback in Imiquimod cutaneous toxicity.”comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c Scientific Reports | (2022) 12:14244 2022 | https://doi.org/10.1038/s41598-022-18671-1
Maryam Bibi , Fakhar ud Din, Yasir Anwar, Naser A. Alkenani, Ali T. Zari ,Muhammad Mukhtiar, Isam M. Abu Zeid, Eman Hilal Althubaiti , Hadiqa Nazish, Alam Zeb, Izhar Ullah, Gul Majid Khan, Han-Gon Cilostazol-loaded solid lipid nanoparticles: Bioavailability and safety evaluation in an animal model , Journal of Drug Delivery Science and Technology,(74):(2022) ( ISSN.NO 1773-2247,2588-8943. HJRS Category W, JCR IF=5.062). 2022 https://doi.org/10.1016/j.jddst.2022.103581
R. Xing, O. Mustapha, T. Ali, M. Rehman, S. S. Zaidi, A. Baseer, S. Batool, Muhammad Mukhtiar, S. Shafique, M. Malik, S. Sohail, Z. Ali, F. Zahid, A. Zeb, F. Shah ,A. Yousaf, and F. Din,” Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery BioMed Research International Volume 2021. (ISSN NO. 2314-6141, 2314-6133 HJRS Category W, JCR IF 3.247). 2021 https://doi.org/10.1155/2021/9968602
Muhammad Akhlaq, Nadia Idrees, Asif Nawaz, Aamir Jalil, Nadiah Zafar,Muhammad Adeel, Izahr Ullah, Muhammad Mukhtiar & Hamid Hussain Afridi . HPMC-co-acrylic acid dexibuprofen once-daily oral hydrogels, Journal of Macromolecular Science, Part A: Pure and Applied Chemistry (2020): (ISSN No.1060-1325 HJRS Category X, JCR IF=2.216). 2020 https://doi.org/10.1080/10601325.2020.1756319
Shamaila Kausar, Sadia Zia, Zainab Nadeem, Mian Anjum Murtaza, Iram Hafiz, Bashir Ahmad Shaheen, Ali Hazrat, Tour Jan, Muhammad Mukhtiar Submerged cultivation of medicinal mushroom in hydrolysate of lingo-cellulosic material Pak. J. Pharm. Sci. 2019:32( 6): (Suppl) 2835-2841. ( ISSN No. 1011-601X HJRS Category W, JCR IF =0.863) 2019
. Jawad Zaheer , Qazi Najmu saqib, Asif Mehmood Hashmi , Muhammad Mukhtiar, Sadia Zafar Ex,Vivo Abortifacient activity of andersac foliosa n-hexane leaves extract on isolated Rabbit Uterus. Pak .J.Pharma. 32(6suppl): 2333-2339, (ISSN No. 1011-601X , HJRS Category W, JCR IF =0.863). 2019
Izharullah, Munasib Khan, Arifullah Khan, Muhammad Akhlaq, Muhammad Mukhtiar & Faisal Rasheed” Chemical Identification, Antibacterial Effect and Synergistic Potential of Mentha arvensis with 5-Fluorouracil against HCT-116 Colon Cancer Cell line Lat. Am. J. Pharm, 2019: 38 (4), 762-70. (HJRS Category W, JCR IF= 0.229). 2019